[HTML][HTML] 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes—2023
NA ElSayed, G Aleppo, VR Aroda, RR Bannuru… - Diabetes …, 2023 - ncbi.nlm.nih.gov
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023
NA ElSayed, G Aleppo, VR Aroda, RR Bannuru… - Diabetes …, 2023 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association …
Heart failure with preserved ejection fraction (HFpEF) represents a highly heterogeneous
clinical syndrome affected in its development and progression by many comorbidities. The …
clinical syndrome affected in its development and progression by many comorbidities. The …
[HTML][HTML] Diabetic nephropathy: focusing on pathological signals, clinical treatment, and dietary regulation
Q Hu, Y Chen, X Deng, Y Li, X Ma, J Zeng… - Biomedicine & …, 2023 - Elsevier
Diabetic nephropathy (DN) is one of the most severe complications of diabetes. However,
due to its complex pathological mechanisms, no effective therapeutic methods (other than …
due to its complex pathological mechanisms, no effective therapeutic methods (other than …
Diabetic nephropathy: update on pillars of therapy slowing progression
SC Naaman, GL Bakris - Diabetes Care, 2023 - Am Diabetes Assoc
Management of diabetic kidney disease (DKD) has evolved in parallel with our growing
understanding of the multiple interrelated pathophysiological mechanisms that involve …
understanding of the multiple interrelated pathophysiological mechanisms that involve …
Hypertension management in patients with cardiovascular comorbidities
Arterial hypertension is a leading cause of death globally. Due to ageing, the rising
incidence of obesity, and socioeconomic and environmental changes, its incidence …
incidence of obesity, and socioeconomic and environmental changes, its incidence …
Primary aldosteronism—a multidimensional syndrome
Primary aldosteronism is a common cause of hypertension and is a risk factor for
cardiovascular and renal morbidity and mortality, via mechanisms mediated by both …
cardiovascular and renal morbidity and mortality, via mechanisms mediated by both …
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional … - Diabetes …, 2022 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
the ADA's current clinical practice recommendations and is intended to provide the …
the ADA's current clinical practice recommendations and is intended to provide the …
Prevention of cardiorenal complications in people with type 2 diabetes and obesity
DJ Drucker - Cell Metabolism, 2024 - cell.com
Traditional approaches to prevention of the complications of type 2 diabetes (T2D) and
obesity have focused on reduction of blood glucose and body weight. The development of …
obesity have focused on reduction of blood glucose and body weight. The development of …
Albuminuria and Heart Failure: JACC State-of-the-Art Review
Although chronic kidney disease is characterized by low glomerular filtration rate (GFR) or
albuminuria, estimated GFR (eGFR) is more widely utilized as a marker of risk profile in …
albuminuria, estimated GFR (eGFR) is more widely utilized as a marker of risk profile in …